Heron Therapeutics Inc vs MINISO Group Holding Ltd — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while MINISO Group Holding Ltd trades at $12.46 (market cap $3.87B). The key difference: MINISO Group Holding Ltd is far larger — about 42.3× Heron Therapeutics Inc's market cap, and MINISO Group Holding Ltd pays a 5.21% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | MNSO | |
|---|---|---|
Market Cap | $91.46M | $3.87B |
Sector | Health | Technology |
52-Week High | $1.96 | $26.63 |
52-Week Low | $0.39 | $11.30 |
Enterprise Value | $189.36M | $4.54B |
Dividend Yield | — | 5.21% |
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →